Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 96. Capino A C, Miller J L, Hughes K M, Miller M J, Johnson P N. Caregiver perception, self-efficacy, and knowledge of methadone tapers for children with iatrogenic opioid abstinence syndrome. Journal of Pharmacy Technology. 2016; 32 : 104-15
97. Liedtke M D, Tomlin C R, Skrepnek G H, Farmer K, Johnson P N, Rathbun C. HIV pharmacist's impact on inpatient antiretroviral errors. HIV Med. 2016
98. Ibach B W, Henry E D, Johnson P N. Acute Kidney Injury in a Child Receiving Vancomycin and Piperacillin/Tazobactam. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2016; 21 : 169-75
99. Johnson P N, Miller J L, Ranallo C. Dosing of Vasopressin in Critically Ill Children: Implications for Medication Safety. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2016; 17 : 277-8
100. Golding C L, Miller J L, Gessouroun M R, Johnson P N. Ketamine Continuous Infusions in Critically Ill Infants and Children. The Annals of pharmacotherapy. 2016; 50 : 234-41
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 6. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.
7. American Society of Health-System Pharmacists Fellow (FASHP). Date: 2021.
8. American Association for Colleges of Pharmacy. Walmart Scholar Mentor (for Laura Salemi). Date: 2020.
9. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.
10. American College of Clinical Pharmacy Pediatric Pharmacy Practice and Research Network. Outstanding Practitioner Award. Date: 2018.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results